FIGURE 1 Given the role of GLP-1 in glycaemic control, the anti-apoptotic, growth-stimulating and insulin secretion-promoting effects on pancreatic -cells, the ability to re-sensitize the cellular insulin-signaling, minor side effects, good tolerance by normoglycemic patients and the fact that GLP-1 does not desensitize, synthetic GLP-1R agonists have been on the market for decades to treat type 2 diabetes mellitus (T2DM) or, more recently, to improve weight loss (Drucker, 2018)
These symptoms typically improve as your body adapts
The medications may also have an ominous side effect thats not often reported
The drug works by mimicking the GLP-1 hormone found naturally in your body
For medical coding GLP-1 medications, accurate coding, documentation, and payer compliance are essential to avoid denials, audits, and recoupments
Psychological treatment of depression in primary care: recent developments